PATTERSON LEONE D — SEC insider filings
SEC reporting owner CIK 1233539. 21 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2021-02-11 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 22,186 shares, $224,158 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 12,471 shares @ $14.10 ($175,841) in Adverum Biotechnologies, Inc., filed 2021-02-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) | President and CFO | 2 | — | 2 legs · 12,533 sh · $176,718 | 1 |
| Tenaya Therapeutics, Inc. (TNYA) | Chief Fin. and Bus. Officer | 5 | — | 2 legs · 9,653 sh · $47,440 | 6 |
| Nkarta, Inc. (NKTX) | Director | 6 | — | — | 6 |
| Zymeworks Inc. (ZYME) | EVP, Chief Bus & Fin Officer | 3 | — | — | 4 |
| Kalaris Therapeutics, Inc. (KLRS) | Director | 2 | — | — | 2 |
| Eliem Therapeutics, Inc. (ELYM) | Director | 1 | — | — | 1 |
| IRulya Therapeutics Inc. (IRLA) | Director | 2 | — | — | 1 |
Insider filings — PATTERSON LEONE D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | IRulya Therapeutics Inc. (IRLA) | Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2026-10-19 | 3 | IRulya Therapeutics Inc. (IRLA) | Holdings only — no transactions reported | EDGAR |
| 2026-06-11 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 459 @ $10.55 | EDGAR |
| 2025-06-09 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 79,000 (derivative) @ $0 · Grant/award (A): 53,000 (derivative) @ $0 | EDGAR |
| 2024-09-03 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 360,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 35,000 @ $0 · Grant/award (A): 205,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 5,201 @ $5.86 | EDGAR |
| 2023-08-18 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 4,452 @ $3.81 | EDGAR |
| 2023-06-09 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 35,000 @ $0 · Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2022-06-01 | 4 | Eliem Therapeutics, Inc. (ELYM) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 66,000 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 16,511 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2021-02-11 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Sale (S): 12,471 @ $14.10 · Sale (S): 62 @ $14.14 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1233539 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs